These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

344 related items for PubMed ID: 14533665

  • 1. Comparisons of the complementary effect on exhaled nitric oxide of salmeterol vs montelukast in asthmatic children taking regular inhaled budesonide.
    Buchvald F, Bisgaard H.
    Ann Allergy Asthma Immunol; 2003 Sep; 91(3):309-13. PubMed ID: 14533665
    [Abstract] [Full Text] [Related]

  • 2. Formoterol, montelukast, and budesonide in asthmatic children: effect on lung function and exhaled nitric oxide.
    Miraglia del Giudice M, Piacentini GL, Capasso M, Capristo C, Maiello N, Boner AL, Capristo AF.
    Respir Med; 2007 Aug; 101(8):1809-13. PubMed ID: 17418554
    [Abstract] [Full Text] [Related]

  • 3. Efficacy and tolerability of salmeterol/fluticasone propionate versus montelukast in childhood asthma: A prospective, randomized, double-blind, double-dummy, parallel-group study.
    Maspero J, Guerra F, Cuevas F, Gutierrez JP, Soto-Ramos M, Anderton S, Mechali D, Chan R, Pedersen S.
    Clin Ther; 2008 Aug; 30(8):1492-504. PubMed ID: 18803991
    [Abstract] [Full Text] [Related]

  • 4. Addition of montelukast or salmeterol to fluticasone for protection against asthma attacks: a randomized, double-blind, multicenter study.
    Ilowite J, Webb R, Friedman B, Kerwin E, Bird SR, Hustad CM, Edelman JM.
    Ann Allergy Asthma Immunol; 2004 Jun; 92(6):641-8. PubMed ID: 15237766
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Switching from salmeterol/fluticasone to formoterol/budesonide combinations improves peripheral airway/alveolar inflammation in asthma.
    Akamatsu T, Shirai T, Kato M, Yasui H, Hashimoto D, Fujisawa T, Tsuchiya T, Inui N, Suda T, Chida K.
    Pulm Pharmacol Ther; 2014 Feb; 27(1):52-6. PubMed ID: 23583566
    [Abstract] [Full Text] [Related]

  • 12. Fluticasone propionate/salmeterol combination provides more effective asthma control than low-dose inhaled corticosteroid plus montelukast.
    Nelson HS, Busse WW, Kerwin E, Church N, Emmett A, Rickard K, Knobil K.
    J Allergy Clin Immunol; 2000 Dec; 106(6):1088-95. PubMed ID: 11112891
    [Abstract] [Full Text] [Related]

  • 13. Double-blind, randomised, controlled trial assessing controller medications in asthma.
    Shah AR, Sharples LD, Solanki RN, Shah KV.
    Respiration; 2006 Dec; 73(4):449-56. PubMed ID: 16407639
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. NO in exhaled air of asthmatic children is reduced by the leukotriene receptor antagonist montelukast.
    Bisgaard H, Loland L, Oj JA.
    Am J Respir Crit Care Med; 1999 Oct; 160(4):1227-31. PubMed ID: 10508811
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Exposure to tobacco smoke increases leukotriene E4-related albuterol usage and response to montelukast.
    Rabinovitch N, Strand M, Stuhlman K, Gelfand EW.
    J Allergy Clin Immunol; 2008 Jun; 121(6):1365-71. PubMed ID: 18439662
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 18.